Inhibition of ATP citrate lyase induces triglyceride accumulation with altered fatty acid composition in cancer cells.
about
Prognostic Value of Malic Enzyme and ATP-Citrate Lyase in Non-Small Cell Lung Cancer of the Young and the Elderly.ATP citrate lyase expression is associated with advanced stage and prognosis in gastric adenocarcinoma.Elovl6 is a poor prognostic predictor in breast cancer.mTOR complex-2 stimulates acetyl-CoA and de novo lipogenesis through ATP citrate lyase in HER2/PIK3CA-hyperactive breast cancerNuclear Phosphoproteomic Screen Uncovers ACLY as Mediator of IL-2-induced Proliferation of CD4+ T lymphocytes.Molecular regulation of apoptotic machinery and lipid metabolism by mTORC1/mTORC2 dual inhibitors in preclinical models of HER2+/PIK3CAmut breast cancer.Analysis of molecular mechanisms of 5-fluorouracil-induced steatosis and inflammation in vitro and in miceSystematic integration of molecular profiles identifies miR-22 as a regulator of lipid and folate metabolism in breast cancer cells.AGXT2L1 is down-regulated in heptocellular carcinoma and associated with abnormal lipogenesis.A distinct function of the retinoblastoma protein in the control of lipid composition identified by lipidomic profiling.Silencing of solute carrier family 13 member 5 disrupts energy homeostasis and inhibits proliferation of human hepatocarcinoma cells.Microarray analysis to identify the similarities and differences of pathogenesis between aortic occlusive disease and abdominal aortic aneurysm.Combination of Mitochondrial and Plasma Membrane Citrate Transporter Inhibitors Inhibits De Novo Lipogenesis Pathway and Triggers Apoptosis in Hepatocellular Carcinoma Cells.Overexpression of ATP citrate lyase in renal cell carcinoma tissues and its effect on the human renal carcinoma cells in vitro.Small-Molecule Modulation of Lipid-Dependent Cellular Processes against Cancer: Fats on the Gunpoint
P2860
Q35593081-16BD733A-7350-45D4-B7FD-A77406DE3042Q35870945-DACAD267-F271-4EA7-B503-31E2367EAB76Q37002333-B4B6A562-CC17-47C3-A753-734E71827DB1Q37295289-68387048-B3F6-485B-96E8-A0AFDD6671D9Q37372247-18AA2ACF-39D6-4A96-A0F5-7DE4CF2AC399Q37687122-8C5CD8E0-2059-45DC-84CC-5C8D6C43F1D0Q37706542-19BC0313-36EC-472C-BB63-1D9F07F4EBC9Q38827031-A1A2DF99-EC3D-4131-A6ED-6F8BC1CCD8F1Q38842092-8DB4ABDC-034A-40CE-84AE-56767682CBEAQ41072298-FA884F31-B860-4A31-B5AB-00A49DA80703Q41484686-910C11E6-B182-4CE1-9E96-5090D13D2843Q47583785-F36033A5-F6D3-498B-BA52-71DFCFD06716Q52726195-0BCF0171-6A40-4422-8B24-74EC0B5622D4Q55347723-7007117E-7E80-4044-BD3F-6313C88995AEQ57169171-3C6E13F7-4C67-4CBE-93AD-6359459A1DA7
P2860
Inhibition of ATP citrate lyase induces triglyceride accumulation with altered fatty acid composition in cancer cells.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Inhibition of ATP citrate lyas ...... d composition in cancer cells.
@en
Inhibition of ATP citrate lyas ...... d composition in cancer cells.
@nl
type
label
Inhibition of ATP citrate lyas ...... d composition in cancer cells.
@en
Inhibition of ATP citrate lyas ...... d composition in cancer cells.
@nl
prefLabel
Inhibition of ATP citrate lyas ...... d composition in cancer cells.
@en
Inhibition of ATP citrate lyas ...... d composition in cancer cells.
@nl
P2093
P2860
P356
P1476
Inhibition of ATP citrate lyas ...... d composition in cancer cells.
@en
P2093
Akihiro Tomida
Kazutaka Ikeda
Ryo Taguchi
Sachiko Okabe
Saori Igarashi
Shoko Sugawara
Tomoyoshi Soga
Toshiro Migita
P2860
P356
10.1002/IJC.28652
P577
2013-12-18T00:00:00Z